The Nguyen Quyen, Van Nguyen Tri, Viet Phuong Nguyen Thuy, Minh Tran Huy, Ngoc Dang Son, Ngoc Hoan Nguyen Bang, Hoang Pham Hai, Tien Tran Trung, Ngoc Tran Dang, Truong Nguyen Vien, Van Nguyen Tan
Department of Geriatrics, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
Department of Interventional Cardiology, Thong Nhat Hospital, Ho Chi Minh City, Vietnam.
Catheter Cardiovasc Interv. 2025 Feb;105(2):335-344. doi: 10.1002/ccd.31251. Epub 2024 Nov 16.
Frailty is associated with poor health outcomes in elderly population. However, its effect on midterm outcomes in elderly patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) remains unknown.
This study aimed to evaluate the association between frailty, as classified by the Clinical Frailty Scale (CFS), and midterm adverse outcomes in elderly STEMI patients after primary PCI.
In this prospective, observational, multicenter cohort study, frailty status of 426 STEMI patients aged ≥60 years undergoing primary PCI was determined using the nine-point CFS 2 weeks before the occurrence of STEMI. Patients scoring at least four points on the CFS were considered frail. The primary outcome was a composite of cardiovascular death or readmission. Secondary outcomes included cardiovascular death, cardiovascular readmission, heart failure-related death or readmission, and myocardial reinfarction. Follow-up data were collected through medical record reviews and/or telephone interviews.
Of 426 elderly patients, 116 were frail. The median follow-up period was 15 months (interquartile range 5-19 months). Primary outcome events occurred in 87 (75.0%) frail and 75 (24.2%) nonfrail patients. The adjusted hazard ratio was 3.278 after model selection using the Bayesian Model Averaging approach (95% confidence interval 2.372-4.531). Multivariate Cox proportional hazard survival analysis showed that frailty was significantly associated with a higher prevalence of all secondary outcome events after adjusting for TIMI, PAMI, and CADILLAC risk scores.
Frailty, as defined by the CFS, was independently associated with midterm adverse outcomes in elderly patients undergoing primary PCI for STEMI.
衰弱与老年人群不良健康结局相关。然而,其对因ST段抬高型心肌梗死(STEMI)接受直接经皮冠状动脉介入治疗(PCI)的老年患者中期结局的影响尚不清楚。
本研究旨在评估根据临床衰弱量表(CFS)分类的衰弱与老年STEMI患者直接PCI术后中期不良结局之间的关联。
在这项前瞻性、观察性、多中心队列研究中,在STEMI发生前2周使用九点CFS确定了426例年龄≥60岁接受直接PCI的STEMI患者的衰弱状态。CFS评分至少4分的患者被视为衰弱。主要结局是心血管死亡或再入院的复合结局。次要结局包括心血管死亡、心血管再入院、心力衰竭相关死亡或再入院以及心肌再梗死。通过病历审查和/或电话访谈收集随访数据。
426例老年患者中,116例衰弱。中位随访期为15个月(四分位间距5 - 19个月)。主要结局事件发生在87例(75.0%)衰弱患者和75例(24.2%)非衰弱患者中。使用贝叶斯模型平均法进行模型选择后,调整后的风险比为3.278(95%置信区间2.372 - 4.531)。多变量Cox比例风险生存分析表明,在调整TIMI、PAMI和CADILLAC风险评分后,衰弱与所有次要结局事件的较高发生率显著相关。
根据CFS定义的衰弱与因STEMI接受直接PCI的老年患者的中期不良结局独立相关。